Cite

HARVARD Citation

    Qiu, R. et al. (2017). Longer-term safety and tolerability of canagliflozin in patients with type 2 diabetes: a pooled analysis. Current medical research and opinion. pp. 553-562. [Online]. 
  
Back to record